Brain zap study probes inflammation link in Parkinson's
NCT ID NCT07673783
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study investigates whether deep brain stimulation (DBS) of the subthalamic nucleus alters inflammation in people with Parkinson's disease. Researchers will measure inflammatory and neurodegenerative markers in the blood of 90 participants before and after DBS surgery, comparing them to a control group receiving only medication. The goal is to understand the biological effects of DBS beyond symptom relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- deep brain stimulation device
- What this could lead to
- If successful, this could reveal how deep brain stimulation reduces brain inflammation in Parkinson's, potentially guiding better treatments.
- What could go wrong
- This is an observational biomarker study, not a treatment trial. It may not show clear links between inflammation and clinical outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Parkinson's pain: could a new Add-On drug bring relief?
- Can virtual games retrain the brain to restore balance?
- Magnetic pulses to the brain may unstick Parkinson's patients who freeze when walking
- Can a pill that blocks a brain protein ease Parkinson's without levodopa?
- Can a zapping helmet ease Parkinson's tremors and speech problems?
- Smartwatch AI could spot Parkinson's years before symptoms